4.7 Article

LncRNA FEZF1-AS1 Promotes Multi-Drug Resistance of Gastric Cancer Cells via Upregulating ATG5

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial)

Keun-Wook Lee et al.

Summary: In patients with metastatic or recurrent gastric cancer, the S-1/oxaliplatin (SOX) regimen showed non-inferiority to the S-1 plus cisplatin (SP) regimen in terms of progression-free survival, with similar overall survival and different toxicity profiles between the two regimens.

GASTRIC CANCER (2021)

Review Pharmacology & Pharmacy

MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity

Milad Ashrafizadeh et al.

Summary: This article discusses the impact of chemoresistance on cancer treatment, emphasizing the importance of autophagy and miRs in cancer cells, as well as their roles in cancer chemotherapy.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Oncology

LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer

Haidong Cheng et al.

Summary: The UCA1/miR-513a-3p/CYP1B1 axis plays a crucial role in regulating cisplatin resistance in human GC cells, providing a potential target for treating chemoresistance in GC.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Otorhinolaryngology

LncRNA FEZF1-AS1 accelerates the migration and invasion of laryngeal squamous cell carcinoma cells through miR-4497 targeting GBX2

Xudong Chen et al.

Summary: FEZF1-AS1, highly expressed in LSCC tissues and cells, promotes cell migration and invasion of LSCC cells by targeting miR-4497 that inhibits GBX2. This finding may provide new therapeutic options for the treatment of LSCC.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Cell Biology

Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation

Yuhao Luo et al.

Summary: Recent studies have shown that lncRNA EIF3J-DT is highly expressed in drug-resistant gastric cancer cells, contributing to chemoresistance by activating autophagy through targeting ATG14. This regulatory mechanism by EIF3J-DT may serve as a potential new target for enhancing chemosensitivity and improving prognosis in gastric cancer patients.

AUTOPHAGY (2021)

Article Cell Biology

The CAGE-MiR-181b-5p-S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells

Minjeong Yeon et al.

Summary: The cancer-associated gene CAGE plays a crucial role in promoting anticancer drug resistance and autophagic flux, while also influencing invasion potential. MiR-181b-5p and S1PR1 may act as negative regulators in controlling the expression of CAGE and autophagic flux.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

Treatment Strategies of Gastric Cancer-Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review

Magdalena Tyczynska et al.

Summary: Recent studies have suggested that molecular targets for anti-angiogenic therapy could be an additional treatment basis for gastric cancer. A systematic literature review was conducted to identify potential strategies for anti-angiogenic therapy in gastric cancer, highlighting the significance of evaluating this treatment in early stages and exploring potential molecular pathways for future therapies.

JOURNAL OF GASTROINTESTINAL CANCER (2021)

Review Pathology

Long non-coding RNA signature in gastric cancer

Soudeh Ghafouri-Fard et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)

Review Biochemistry & Molecular Biology

Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies

Julita Machlowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Gastric cancer: a comprehensive review of current and future treatment strategies

Rachel E. Sexton et al.

CANCER AND METASTASIS REVIEWS (2020)

Review Cell Biology

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Jing-Li Xu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Cell & Tissue Engineering

LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2

Yuanjian Hui et al.

CELL TRANSPLANTATION (2020)

Review Gastroenterology & Hepatology

Progress in the treatment of gastric cancer in Japan over the last 50 years

Mitsuru Sasako

ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)

Review Medicine, Research & Experimental

Autophagy: A novel mechanism of chemoresistance in cancers

Xinyu Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Medical Laboratory Technology

Long noncoding RNA FEZF1-AS1 in human cancers

Yuanshi Zhou et al.

CLINICA CHIMICA ACTA (2019)

Review Oncology

Non-coding RNA in drug resistance of gastric cancer

Ya-Jun Luo et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)

Review Oncology

Emerging role of long non-coding RNA in the development of gastric cancer

Hang Yu et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy

Peng Yuan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance

Xian-wen Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Biochemistry & Molecular Biology

Long Noncoding RNA MRUL Promotes ABCB1 Expression in Multidrug-Resistant Gastric Cancer Cell Sublines

Ying Wang et al.

MOLECULAR AND CELLULAR BIOLOGY (2014)

Review Gastroenterology & Hepatology

Genetics of gastric cancer

Main I. H. McLean et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Treatment of gastric cancer

Michele Orditura et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Medicine, General & Internal

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Shinichi Sakuramoto et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)